Loxo Oncology, Inc. (LOXO) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Loxo Oncology, Inc. stock price
Loxo Oncology, Inc. latest news:
Loxo, Bayer to co-develop cancer drugs in up to $1.55 bln deal
Loxo Oncology Inc(LOXO) will collaborate with Germany's Bayer AG to develop and commercialize two of its cancer therapies, the companies said on Tuesday, in deal that could bring the U.S. drug developer up to $1.55 billion. The drugs - larotrectinib and follow-on compound LOXO-195 - are TRK inhibitors, which directly target an acquired rather than inherited genetic defect.